The global amlodipine besylate market is anticipated to grow at a significant CAGR of 8.2% during the forecast period. Amlodipine decreases blood pressure by relaxing blood arteries, reducing the risk of heart attacks, strokes, and kidney disease. As a result, the high prevalence of heart disease around the globe may increase the demand for amlodipine besylate. Depending on the patient's history of heart attack, stroke, cardiac arrest, or stroke, healthcare providers can raise or decrease the dose. Smoking, diabetes, obesity, lack of physical exercise, vitamin D deficiency, stress, and high salt or alcohol intake levels are the most prevalent causes of hypertension. For instance in 13 September 2019, According to WHO data 1.13 billion people worldwide have hypertension, with the majority (two-thirds) living in middle and low-income nations. As a result, as the number of patients grows, so does the demand for the product on the market. 

Impact of COVID-19 Pandemic on Global Amlodipine Besylate Market

Businesses across many industries have faced the effects of lockdown and government-imposed limitations as a result of COVID-19. The private healthcare sector, as well as health firms that rely on intimate personal contact with their customers, have been severely impacted. Several small hospitals, clinics, and nursing homes have had to close their doors. Procedures have been delayed as a result of social alienation and localized curfews. Furthermore, visa cancellations have caused a halt in medical tourism, which may have a detrimental impact on the growth of the global amlodipine besylate market. 

Segmental Outlook 

The global amlodipine besylate market is segmented based on the type and application. Based on the type, the market is segmented into 2.5mg tablets, 5mg tablets, and 10mg tablets. Based on the application, the market is sub-segmented into high blood pressure and heart disease. Among these, the application segment is anticipated to propel the growth of the market over the forecast period, owing to rising hypertension in the population around the globe. 

Global Amlodipine Besylate Market Share by Application, 2021 (%)

The Heart Disease Segment is Anticipated to Hold a Prominent Share in the Global Amlodipine Besylate Market

Heart Disease is anticipated to hold the largest share in the market owing to due to changing lifestyles and increasing obesity. According to Centers for Disease Control and Prevention nearly half of adults in the United States (47%, or 116 million) have hypertension, defined as a systolic blood pressure greater than 130 mmHg or diastolic blood pressure greater than 80 mmHg or are taking medication for hypertension. Due to the rising global prevalence of coronary artery disease, the chronic stable angina segment is predicted to grow at a high rate throughout the forecast timeline. According to the Lancet's most recent publication, 18% of individuals worldwide suffer from coronary artery disease. For instance, Micro Labs Ltd. offers Amlong 5 Tablet 15's belongs to a class of medicines called calcium channel blockers which are primarily taken for the treatment of hypertension (high blood pressure) and angina (chest pain). Hypertension (high blood pressure) is a lifelong or chronic condition in which the force exerted by the blood against the artery walls becomes high. The higher this blood pressure, the harder the heart has to pump. 

Regional Outlooks

The global amlodipine besylate market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The Asia-Pacific regional Amlodipine Besylate market is expected to hold a prominent market share due to the rise in consumption of alcohol, tobacco products, and junk foods.

Global Amlodipine Besylate Market Growth, by Region 2022-2028

The Asia-Pacific Region is estimated to Hold the Major Share in the Global Amlodipine Besylate Market

The Asia-Pacific is anticipated to hold a prominent share in the market. With the development of the economy and the aging of the population, as well as changing lifestyles and eating habits, the incidence of hypertension is rising across the Asia Pacific area. As a result of the increased number of hypertension patients in the region, the market for amlodipine besylate is also expanding. For instance; Indizen Pharmaceutical offers Amlozen AT 5mg/50mg Tablet is a combination medicine that contains two active ingredients, Amlodipine and Atenolol. Both of the medicines in this combination work to lower blood pressure but in different ways. Together they help to relax blood vessels, reduce heart rate and make it easier for your heart to pump blood around your body. This lowers blood pressure and reduces hypertension.

Market Players Outlook

The major companies serving the global amlodipine besylate market include Apotex Inc., Aurobindo Pharma Ltd., China Resources Pharmaceutical Group Ltd., Macleods Pharmaceuticals Ltd., Pfizer Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, Teva Pharmaceutical Industries Ltd. launched a generic medicine that offers the same use as Exforge has, named Amlodipine and Valsartan Tablets

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global amlodipine besylate market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.